Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2013 Mar-Apr;51(2):192-9.

[Economic cost of polypharmacy in the elderly in primary health care].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Unidad de Investigación Epidemiológica y en Servicios de Salud, Instituto Mexicano del Seguro Social, Querétaro, México. felibree@infosel.net.mx.

Abstract

in English, Spanish

OBJECTIVE:

to quantify the economic cost of polypharmacy in the elderly.

METHODS:

cost study design, made in two first-level medical units. The study was conducted in 131 older adult patients with polypharmacy, chronic degenerative disease and at least one medical visit per year. The sample was calculated using the formula of finite population averages. The cost of polypharmacy was assessed in medical consultation, medicine and pharmacy services. The evaluation of the medical cost included the number of visits per year for the same unit cost, the cost of medicine considered the amount of drug per year for the same unit cost, and the cost of the service pharmacy took into account the number of times the pharmacy occupies the unit cost of the same. The statistical analysis included means, percentages and confidence intervals.

RESULTS:

in family practice the average annual cost is $1,263.26. In pharmacy the average annual cost is $229.91. The average time drug use is 4.37 months per year (95 % CI = 0.9-7.9), the annual average cost drugs is $708.00. Considering the three dimensions the annual cost of polypharmacy in the elderly is $2,201.17.

CONCLUSIONS:

the cost of polypharmacy is high and represents a significant economic impact.

KEYWORDS:

aged; cost-benefit analysis; polypharmacy

PMID:
23693109
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center